Super Micro Computer SMCI

Reference table

1. What it is

Super Micro Computer (NASDAQ: SMCI), founded 1993 and based in San Jose, is a total IT-solutions provider — it designs and assembles servers, storage, and full data-center racks, now overwhelmingly for AI training and inference (liquid- and air-cooled GPU systems). Its edge historically has been a modular "Server Building Block" design philosophy that lets it be first-to-market with each new Nvidia/AMD GPU generation. CEO and founder Charles Liang still runs it. Fiscal year ends June 30.

Revenue mix (FY2025, from filings):

• By product: Server & Storage Systems $21.31B (97%) · Subsystems & accessories $0.66B. This is effectively a one-product company — full-system AI servers.
• By geography: United States $13.05B (59%) · Asia $5.49B (25%) · Europe $2.73B (12%) · other $0.70B. The business is US-centric but with meaningful Asia exposure — relevant to the export-control review (§11).

The strategic story is SMCI's shift from a components/board maker to a rack-scale "total data-center" provider (its DCBBS — Data Center Building Block Solutions — line, plus new Silicon Valley manufacturing), riding on direct-liquid-cooling (DLC) as a differentiator.

2. The expert thesis — thin coverage, read with caution (traceable)

Synthos KB coverage here is thin and one-sided: 4 total claims, exactly 1 net-bullish voice. This is not a conviction-track name — the verdict is driven by fundamentals and quant, not by a broad expert panel. Say so plainly.

• The single bullish voice is Jensen Huang (jensen_huang_ai-VOdVO7qMzZs:928142e1f6, bullish, conviction 70, 2025-05-19): "Super Micro leads direct-liquid-cooling; new DLC2 cuts power/water ~40% and TCO ~20%, expanding its data-center market share." That is a real, specific technology claim about SMCI's cooling edge.
• Honest weighting — this is a conflicted source. Huang is the CEO of Nvidia, whose GPUs SMCI resells inside its servers; SMCI is effectively Huang's channel partner. He is talking his own book. Treat this as informed color on the cooling technology, not as independent conviction on the equity.

There is no independent, high-skill bull thesis in the Synthos KB for SMCI, and no distilled bear voice either. The absence of coverage is itself a signal: this is a name our expert panel has largely not underwritten. Accordingly, everything below leans on the hard financials and the quant read, and the verdict reflects that.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores summarize them.

Synthos fair value = the base case, ~$30 (+10%), with the full $15–$49 span as the honest range. Our anchor sits below the Street's $38.6 consensus — we give less credit to the margin recovery embedded in the sell-side numbers and more weight to the governance overhang. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). SMCI is neither cleanly — it is a high-growth, low-quality cyclical past its steepest acceleration:

• Forward growth: revenue CAGR FY25→FY28E ~40% ($21.97B → $60.1B on consensus); EPS CAGR is far tamer — TTM $2.09 → FY29E $3.54 is only ~14%/yr, because margin, share dilution, and interest expense eat the top-line growth.
• Acceleration (the 2nd derivative) is sharply negative: consensus revenue FY26E $39.7B (+81% on FY25) → FY27E $51.4B (+29%) → FY28E $60.1B (+17%) → FY29E $60.9B (+1%). The hyper-growth is a pull-forward off the AI-capex wave; the estimates themselves show it flattening within three years. The earnings line decelerates even faster (FY26E→FY29E EPS CAGR ~11%).
• Room to run: at $17.6B the market cap is small versus the AI-infrastructure TAM, so on a pure size-vs-TAM basis there is room. But the binding constraint isn't demand — it's who captures the margin. In a commodity box, TAM headroom does not convert to shareholder value.
• Reinvestment runway: SMCI reinvests heavily (inventory + capacity), but with negative operating cash flow and rising debt, the reinvestment is being funded by the balance sheet, not internal cash — the opposite of a self-funding compounder.

Exponential Potential: Moderate (5/10). The AI wave is real and SMCI is small enough to matter, but decelerating growth on razor-thin, low-quality margins is not the profile of a durable multibagger. Own the theme through higher-quality names; SMCI is the beta, not the alpha.

5. Financials (real numbers — FMP annual/quarterly)

• Revenue: FY25 $21.97B, +46.6% (FY24 $14.99B, +110% on FY23 $7.12B). Explosive top line — the one unambiguous strength.
• Quarterly trajectory (volatile, not clean): Q1 FY26 $5.02B → Q2 $12.68B → Q3 $10.24B. The sequential swings (and the huge Q2) reflect lumpy large-cluster AI deals — revenue is less predictable than a compounder's, exactly as management warns.
• Margins — the core problem: gross margin 8.4% TTM (FY25 ~11.1%, FY24 13.8%). Per the Q3 FY26 release, GAAP gross margin was 9.9% (up from a startling 6.3% in Q2 FY26, but down from prior years). Net margin 3.7% TTM. This is the crux: SMCI is being squeezed by GPU cost pass-through, price competition, and mix.
• Earnings: net income ~$1.05B FY25 (EPS $1.77 GAAP / $1.68 diluted). TTM net income per share ~$2.09. Q3 FY26 diluted EPS $0.72 GAAP / $0.84 non-GAAP.
• Cash flow — the red flag: FY25 operating cash flow was +$1.66B, but the AI ramp is enormously working-capital-hungry — Q3 FY26 alone used $6.6 billion in operating cash (inventory + receivables build). TTM operating and free cash flow are negative (FMP: FCF yield −39%). Growth here consumes cash rather than generating it.
• Balance sheet — deteriorated: FY25 year-end showed net cash (net debt −$0.39B), but the Q3 FY26 release states $1.3B cash vs $8.8B bank debt + convertible notes → net debt swung to ~$7.5B. TTM net-debt/EBITDA ~3.1×. The cash burn is being funded with debt and equity (convertibles), and diluted share count has risen toward ~700M.

6. Valuation — cheap, or a value trap?

On the screen SMCI looks cheap: 13× trailing EPS, 10.5× FY26E, 8.6× FY27E, 0.68× EV/sales, 13× EV/EBITDA (7.2× forward). Those are not AI-darling multiples. The bear's rebuttal is that the multiple is low because the earnings are low-quality: an 8-10% gross-margin assembler with negative operating cash flow, rising debt, and an open investigation should trade at a distressed multiple. The whole bull case is a margin-recovery + de-cloud-the-governance call — if GAAP gross margin re-rates back toward 12%+ and the review clears, today's price is genuinely cheap; if margins stay ~9%, the "cheap" forward EPS never fully arrives and the low multiple is correct.

Street targets (context): consensus $38.6, high $45, low $26; grades 0 Strong Buy / 9 Buy / 14 Hold / 2 Sell → Hold. Our ~$30 base FV is below consensus — we weight the governance and margin risk more heavily than the sell-side average. FMP's own letter rating is B (overall score 3/5), dragged down by DCF (1/5) and debt-to-equity (1/5) sub-scores. Not a value buy on our read; a show-me at best.

7. Technicals (from the tech block)

• Trend: down. $27.22 sits below the 50-DMA ($33.46) and 200-DMA ($35.02), with the 50 below the 200 (death-cross posture). MACD −1.97 (negative).
• Location: −55% off the 52-week high ($60.71), +33% off the 52-week low ($20.53), with a brutal max drawdown of −77% from peak. This is a broken-momentum chart, not a leadership name.
• Momentum: RSI(14) 40 — weak, but not yet washed-out/oversold (<30).
• Relative strength (the tell): SMCI −42.3% 12-mo vs SPY +20.6% and QQQ +30.3% — massive underperformance of both the market and the tech index. It did bounce +20.9% over 3 months (roughly matching QQQ +22%), so the very-near-term stopped bleeding, but 6-mo is still −8.2%.
• Read: technicals confirm the caution — a downtrend below both moving averages with a history of violent drawdowns. No technical "all-clear." A base above the 200-DMA (~$35) with margin evidence would be the earliest constructive signal.

8. Moat & competitive position

SMCI's "moat" is narrow and contested. Its genuine edges are (1) speed-to-market with each new GPU generation via modular design, and (2) a real lead in direct-liquid-cooling at rack scale — the one point the KB's single bull (Jensen Huang, jensen_huang_ai-VOdVO7qMzZs:928142e1f6) endorses. But the business is fundamentally assembly of other people's silicon: the ~8% gross margin is the moat test, and it is failing it. SMCI is squeezed between (a) ODMs (Quanta, Wistron, Foxconn) that undercut on price, (b) tier-1 OEMs (Dell, HPE) with deeper enterprise relationships, and (c) hyperscaler self-build, where the largest AI buyers design their own racks and cut SMCI out. Low switching costs, commodity inputs, price-taker economics.

Peer set (FMP-provided, market cap): Hewlett Packard Enterprise $54.6B (the closest server comp), HP Inc. $20.1B, NetApp $30.2B, Pure Storage $28.5B, Teradyne $57.8B, Keysight $53.6B, MongoDB $28.5B, Broadridge $16.6B, Sandisk $258B, Rigetti $6.0B. The relevant comps (HPE, NTAP, PSTG) carry higher and more stable margins than SMCI — the multiple gap is a quality gap, not a mispricing.

9. Management, capital allocation & guidance

• Capital allocation: aggressive, balance-sheet-funded growth — heavy inventory/capacity build funded by new debt and convertibles (net debt swung from net-cash to ~$7.5B in a year) plus a $200M buyback in FY25. At negative operating cash flow, this is high-risk reinvestment, not shareholder-friendly capital return.
• Governance overhang (the differentiator): the Q3 FY26 earnings release states "the Board is conducting an independent review of certain transactions in connection with export-control issues," and explicitly warns the outcome "could affect our forecasts, these preliminary results and prior period results." SMCI also has a history of accounting-related scrutiny. This is a live, unresolved red flag, not boilerplate.
• Insider activity: the most recent Form 4s (filed 2026-07-02) are director/10%-owner Sara Liu's routine RSU vesting and tax-withholding ("F-InKind" at $27.65, "M-Exempt" at $0) — small, non-discretionary, not a signal either way.
• Management's own guidance (half-weighted — their own book): in the 2026-05-05 earnings release (SEC 8-K, Item 2.02), management guided Q4 FY26 net sales of $11.0–12.5B, GAAP diluted EPS $0.53–0.67 (non-GAAP $0.65–0.79), and full-year FY26 net sales of $38.9–40.4B (assuming ~695M GAAP diluted shares). CEO Charles Liang framed it as "margin recovery and the rapid growth of our DCBBS business." Treat as self-interested: it is preliminary, unaudited, and explicitly caveated as subject to the ongoing review. It does corroborate the ~$40B FY26 revenue base and a claimed margin recovery — but it is management's own words, half-weighted.

10. Catalysts & what to watch

• Next earnings: 2026-08-04 (Q4 FY26; Street EPS $0.70, revenue ~$11.7B). The single most important line is GAAP gross margin — does the Q3 recovery (9.9%) hold or extend, or was it a one-quarter blip?
• Export-control board review: any resolution, charge, or prior-period restatement — the biggest binary overhang.
• Operating cash flow: does the working-capital burn reverse as the inventory build converts to sales, or does the balance sheet keep funding growth?
• DLC / DCBBS traction: rack-scale and liquid-cooling mix as the margin lever (the Huang thesis).
• Competitive: hyperscaler self-build and ODM pricing — the structural margin threat.

Thesis tripwires (what would change the call — to the upside): two consecutive quarters of GAAP gross margin above ~11%; operating cash flow turning durably positive; and a clean close to the export-control review. Any one of a restatement, a sub-8% margin quarter, or a covenant/debt scare would push the call toward Avoid.

11. Key risks

• Structural margin compression (core): ~8-10% gross margin in a commodity build; if it stays here, the "cheap" forward EPS is illusory. This is the single biggest risk.
• Governance / export-control review: an open, board-level investigation that management says could restate prior periods — an equity-specific overhang most peers don't carry.
• Balance-sheet & cash-flow risk: negative operating cash flow, net debt swung to ~$7.5B, ~$8.8B bank debt + convertibles — leverage on a cyclical, low-margin book.
• Customer & product concentration: ~97% of revenue is one product line (AI servers), sold increasingly to a few large customers; management itself flags concentration and less-predictable sales.
• Cyclicality / hyperscaler self-build: SMCI is high-beta (1.87) exposure to the AI-capex cycle, with the largest buyers able to design it out.
• Dilution: rising diluted share count (~700M) via convertibles quietly erodes per-share value.

12. Verdict, position sizing & monitoring

Watch. SMCI is a genuinely fast-growing beneficiary of the AI-server build-out that screens cheap (8-10× forward EPS), and its direct-liquid-cooling lead is real — the one point our single (conflicted) expert voice endorses. But the quality is poor: ~8% gross margin, negative operating cash flow, net debt swung to ~$7.5B, high beta, a −77% drawdown history, and — decisively — an open export-control board review that management says could restate prior periods. Cheapness does not offset an unresolved governance cloud plus a structurally thin margin. This is a "prove-it-first" name, not a buy.

• Sizing: watch-list only — no core position. For risk-tolerant investors, at most a small, sized-to-lose satellite after a margin inflection and review resolution, never a core weight.
• What flips it to a Buy: two-plus quarters of GAAP gross margin >11%, operating cash flow turning positive, and a clean close to the export-control review — at which point the low multiple becomes a genuine opportunity.
• Monitoring: re-underwrite each earnings print on margin + cash flow; watch for any 8-K on the review. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $27.22.
• Single biggest risk: structural gross-margin compression on top of the unresolved export-control review.

Provenance & disclosures

• Traceability: 4 KB claims, breadth 1 net-bullish voice, last claim 2025-05-19 — the single cited claim_id (jensen_huang_ai-VOdVO7qMzZs:928142e1f6) is real and reconciled. This is a thin-coverage name; the verdict is fundamentals- and quant-driven, not conviction-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation).
• Conflict flag: the lone bullish voice (Jensen Huang) is Nvidia's CEO and SMCI's key supplier/channel partner — informed on the cooling technology, but talking his own book on the equity.
• Data as-of: fundamentals 2026-03-31 (Q3 FY26) · estimates & prices 2026-07-02/03 · expert claims through 2025-05-19. Forward figures are analyst consensus (FMP) or our scenario model, labeled as estimates.
• Management caveat: the FY26 guidance summarized in §9 is management's own, half-weighted by design, and is explicitly preliminary/unaudited and subject to the ongoing board review.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").